Literature DB >> 28329353

Prediagnosis Sleep Duration, Napping, and Mortality Among Colorectal Cancer Survivors in a Large US Cohort.

Qian Xiao1, Hannah Arem2, Ruth Pfeiffer3, Charles Matthews3.   

Abstract

Study
Objectives: Prediagnosis lifestyle factors can influence colorectal cancer (CRC) survival. Sleep deficiency is linked to metabolic dysfunction and chronic inflammation, which may contribute to higher mortality from cardiometabolic conditions and promote tumor progression. We hypothesized that prediagnosis sleep deficiency would be associated with poor CRC survival. No previous study has examined either nighttime sleep or daytime napping in relation to survival among men and women diagnosed with CRC.
Methods: We examined self-reported sleep duration and napping prior to diagnosis in relation to mortality among 4869 CRC survivors in the NIH-AARP Diet and Health Study. Vital status was ascertained by linkage to the Social Security Administration Death Master File and the National Death Index. We examined the associations of sleep and napping with mortality using traditional Cox regression (total mortality) and Compositing Risk Regression (cardiovascular disease [CVD] and CRC mortality). Models were adjusted for confounders (demographics, cancer stage, grade and treatment, smoking, physical activity, and sedentary behavior) as well as possible mediators (body mass index and health status) in separate models.
Results: Compared to participants reporting 7-8 hours of sleep per day, those who reported <5 hr had a 36% higher all-cause mortality risk (Hazard Ratio (95% Confidence Interval), 1.36 (1.08-1.72)). Short sleep (<5 hr) was also associated with a 54% increase in CRC mortality (Substitution Hazard Ratio (95% Confidence Interval), 1.54 (1.11-2.14)) after adjusting for confounders and accounting for competing causes of death. Compared to no napping, napping 1 hr or more per day was associated with significantly higher total and CVD mortality but not CRC mortality.
Conclusion: Prediagnosis short sleep and long napping were associated with higher mortality among CRC survivors. © Sleep Research Society 2017. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  colorectal cancer; mortality.; napping; sleep

Mesh:

Year:  2017        PMID: 28329353      PMCID: PMC5806565          DOI: 10.1093/sleep/zsx010

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  35 in total

1.  Pre- and postdiagnosis physical activity, television viewing, and mortality among patients with colorectal cancer in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Hannah Arem; Ruth M Pfeiffer; Eric A Engels; Catherine M Alfano; Albert Hollenbeck; Yikyung Park; Charles E Matthews
Journal:  J Clin Oncol       Date:  2014-12-08       Impact factor: 44.544

Review 2.  Daytime napping and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies.

Authors:  Guochao Zhong; Yi Wang; TieHong Tao; Jun Ying; Yong Zhao
Journal:  Sleep Med       Date:  2015-04-21       Impact factor: 3.492

Review 3.  Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation.

Authors:  Michael R Irwin; Richard Olmstead; Judith E Carroll
Journal:  Biol Psychiatry       Date:  2015-06-01       Impact factor: 13.382

4.  A colorectal cancer classification system that associates cellular phenotype and responses to therapy.

Authors:  Anguraj Sadanandam; Costas A Lyssiotis; Krisztian Homicsko; Eric A Collisson; William J Gibb; Stephan Wullschleger; Liliane C Gonzalez Ostos; William A Lannon; Carsten Grotzinger; Maguy Del Rio; Benoit Lhermitte; Adam B Olshen; Bertram Wiedenmann; Lewis C Cantley; Joe W Gray; Douglas Hanahan
Journal:  Nat Med       Date:  2013-04-14       Impact factor: 53.440

Review 5.  The insulin-like growth factor axis: A biological mechanism linking physical activity to colorectal cancer survival.

Authors:  Andrew T Sax; David G Jenkins; James L Devin; Gareth I Hughes; Kate A Bolam; Tina L Skinner
Journal:  Cancer Epidemiol       Date:  2014-06-23       Impact factor: 2.984

6.  Sleep disturbance in cancer patients.

Authors:  Judith R Davidson; Alistair W MacLean; Michael D Brundage; Karleen Schulze
Journal:  Soc Sci Med       Date:  2002-05       Impact factor: 4.634

7.  Sleep duration and total and cause-specific mortality in a large US cohort: interrelationships with physical activity, sedentary behavior, and body mass index.

Authors:  Qian Xiao; Sarah K Keadle; Albert R Hollenbeck; Charles E Matthews
Journal:  Am J Epidemiol       Date:  2014-10-03       Impact factor: 4.897

8.  The impact on National Death Index ascertainment of limiting submissions to Social Security Administration Death Master File matches in epidemiologic studies of mortality.

Authors:  Sigurd W Hermansen; Michael F Leitzmann; Arthur Schatzkin
Journal:  Am J Epidemiol       Date:  2009-02-27       Impact factor: 4.897

Review 9.  Inflammatory bowel disease and colon cancer.

Authors:  Noor Jawad; Natalie Direkze; Simon J Leedham
Journal:  Recent Results Cancer Res       Date:  2011

10.  Associations between change in sleep duration and inflammation: findings on C-reactive protein and interleukin 6 in the Whitehall II Study.

Authors:  Jane E Ferrie; Mika Kivimäki; Tasnime N Akbaraly; Archana Singh-Manoux; Michelle A Miller; David Gimeno; Meena Kumari; George Davey Smith; Martin J Shipley
Journal:  Am J Epidemiol       Date:  2013-06-25       Impact factor: 4.897

View more
  6 in total

1.  Sleep duration and napping in relation to colorectal and gastric cancer in the MCC-Spain study.

Authors:  Kyriaki Papantoniou; Gemma Castaño-Vinyals; Ana Espinosa; Michelle C Turner; Vicente Martín-Sánchez; Delphine Casabonne; Nuria Aragonés; Inés Gómez-Acebo; Eva Ardanaz; Jose-Juan Jimenez-Moleon; Pilar Amiano; Ana Molina-Barceló; Juan Alguacil; Guillermo Fernández-Tardón; José María Huerta; Natalia Hernández-Segura; Beatriz Perez-Gomez; Javier Llorca; Juana Vidán-Alli; Rocıo Olmedo-Requena; Leire Gil; Carmen Castañon-López; Marina Pollan; Manolis Kogevinas; Victor Moreno
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

2.  Chronic disease management perspectives of colorectal cancer survivors using the Veterans Affairs healthcare system: a qualitative analysis.

Authors:  Leah L Zullig; Karen M Goldstein; Hayden B Bosworth; Sara M Andrews; Susanne Danus; George L Jackson; Dawn Provenzale; Morris Weinberger; Michael J Kelley; Corrine I Voils
Journal:  BMC Health Serv Res       Date:  2018-03-09       Impact factor: 2.655

3.  The Role of Healthy Lifestyle in Cancer Incidence and Temporal Transitions to Cardiometabolic Disease.

Authors:  Zhi Cao; Chenjie Xu; Hongxi Yang; Shu Li; Yaogang Wang
Journal:  JACC CardioOncol       Date:  2021-12-21

4.  Health-Promoting Lifestyle in Colorectal Cancer Survivors: A Qualitative Study on the Experiences and Perspectives of Colorectal Cancer Survivors and Healthcare Providers.

Authors:  Elahe Ramezanzade Tabriz; Monir Ramezani; Abbas Heydari; Seyed Amir Aledavood
Journal:  Asia Pac J Oncol Nurs       Date:  2021-10-04

5.  Circadian and chemotherapy-related changes in urinary modified nucleosides excretion in patients with metastatic colorectal cancer.

Authors:  S Dulong; Q Huang; P F Innominato; A Karaboue; M Bouchahda; A Pruvost; F Théodoro; L A Agrofoglio; R Adam; B Finkenstädt; F Lévi
Journal:  Sci Rep       Date:  2021-12-14       Impact factor: 4.379

Review 6.  The Association of Sleep Disorders, Obesity and Sleep-Related Hypoxia with Cancer.

Authors:  Anna Brzecka; Karolina Sarul; Tomasz Dyła; Marco Avila-Rodriguez; Ricardo Cabezas-Perez; Vladimir N Chubarev; Nina N Minyaeva; Sergey G Klochkov; Margarita E Neganova; Liudmila M Mikhaleva; Siva G Somasundaram; Cecil E Kirkland; Vadim V Tarasov; Gjumrakch Aliev
Journal:  Curr Genomics       Date:  2020-09       Impact factor: 2.236

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.